Of course but I think its unlikely a huge coincidence that the complaint specifically mentiones Jakafi which is NOvartis drug in the paeds GVHD space and then suddenly ODAC gets over-ruled by the FDA and then a Novartis partnership announced? You are right there is not a visable fire but a hell of a lot of smoke to me....
Why would a competitor do that, they would be happy to see Novartis get roasted by wasting money on Jakafi. I think it makes sense for Novartis to apply a lot of pressure to MSB covertly before negotiationg by doing this and then coming in to "help them" get it and ARDS over the line when their ARDS drug (Jakavi) also just failed?
http://www.pharmafile.com/news/566248/novartis-and-incytes-ruxolitinib-fails-show-benefit-covid-19-phase-3
This happened after that by 2 months but they must have known at this time it was not going to fly either?
- Forums
- ASX - By Stock
- MSB
- MSB to dispute FDA finding in Type A meeting
MSB to dispute FDA finding in Type A meeting, page-752
-
-
- There are more pages in this discussion • 266 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
|
|||||
Last
$1.18 |
Change
0.015(1.29%) |
Mkt cap ! $1.330B |
Open | High | Low | Value | Volume |
$1.15 | $1.18 | $1.15 | $789.2K | 679.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
23 | 37834 | $1.18 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.18 | 32211 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
10 | 32505 | 1.180 |
22 | 69799 | 1.175 |
18 | 161977 | 1.170 |
11 | 67759 | 1.165 |
10 | 65655 | 1.160 |
Price($) | Vol. | No. |
---|---|---|
1.185 | 72557 | 8 |
1.190 | 97752 | 15 |
1.195 | 114340 | 12 |
1.200 | 70379 | 15 |
1.205 | 20000 | 1 |
Last trade - 10.40am 16/07/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
RCE
RECCE PHARMACEUTICALS LTD
James Graham / Dr Alan Dunton, MD & CEO / Non-Executive Director
James Graham / Dr Alan Dunton
MD & CEO / Non-Executive Director
SPONSORED BY The Market Online